380 related articles for article (PubMed ID: 4948417)
1. Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains.
Mel D; Gangarosa EJ; Radovanovic ML; Arsic BL; Litvinjenko S
Bull World Health Organ; 1971; 45(4):457-64. PubMed ID: 4948417
[TBL] [Abstract][Full Text] [Related]
2. Studies on vaccination against bacillary dysentery. 3. Effective oral immunization against Shigella flexneri 2a in a field trial.
Mel DM; Terzin AL; Vuksić L
Bull World Health Organ; 1965; 32(5):647-55. PubMed ID: 5294180
[TBL] [Abstract][Full Text] [Related]
3. Live oral Shigella vaccine: vaccination schedule and the effect of booster dose.
Mel DM; Arsic BL; Radovanovic ML; Litvinjenko SA
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):109-14. PubMed ID: 4613128
[No Abstract] [Full Text] [Related]
4. Studies on vaccination against bacillary dysentery. 4. Oral immunization with live monotypic and combined vaccines.
Mel DM; Arsić BL; Nikolić BD; Radovanić ML
Bull World Health Organ; 1968; 39(3):375-80. PubMed ID: 5303905
[TBL] [Abstract][Full Text] [Related]
5. Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children.
Ashkenazi S; Passwell JH; Harlev E; Miron D; Dagan R; Farzan N; Ramon R; Majadly F; Bryla DA; Karpas AB; Robbins JB; Schneerson R
J Infect Dis; 1999 Jun; 179(6):1565-8. PubMed ID: 10228084
[TBL] [Abstract][Full Text] [Related]
6. Oral immunization of monkeys with polyvalent dysentery vaccine.
Dhikidze EK; Kavtaradze KN; Krilova RI; Rauss K; Kétyi I; Vertényi A
Acta Microbiol Acad Sci Hung; 1977; 24(1):7-12. PubMed ID: 412396
[TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
[TBL] [Abstract][Full Text] [Related]
8. Technological aspect of the production of live dysentery vaccines for oral administration.
Denchev V; Nenkov P; Vitanov T; Sumerska T; Marinova S; Vassilev T; Panova I; Bratoeva M; Linde K
Acta Microbiol Hung; 1991; 38(2):121-6. PubMed ID: 1805499
[TBL] [Abstract][Full Text] [Related]
9. [Safety, reactivity and effectiveness testing of live shigella flexneri vaccines in laboratory animals and children (author's transl)].
Sergeev VV; Elkina SI; Solodnikov YP; Shuster BY; Sergeeva GS; Bulk VF; Bobkin SV
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):121-8. PubMed ID: 4216247
[No Abstract] [Full Text] [Related]
10. [Live vaccines for the prevention of intestinal infections].
Sergeev VV; Kreynin LS; Lichoded VG; Elkina CU; Zukova LF; Kaverina KG
Arch Exp Veterinarmed; 1980; 34(1):87-9. PubMed ID: 6998403
[TBL] [Abstract][Full Text] [Related]
11. Studies on vaccination against bacillary dysentery. 2. Safety tests and reactogenicity studies on a live dysentery vaccine intended for use in field trials.
Mel DM; Papo RG; Terzin AL; Vuksić L
Bull World Health Organ; 1965; 32(5):637-45. PubMed ID: 5294179
[TBL] [Abstract][Full Text] [Related]
12. [Prevention of bacillary dysentery using a live anti-dysentery vaccine in a group of neuropsychopathic children].
Meitert T; Istrati G; Sulea IT; Baron E; Andronescu C; Gogulescu L; Templea C; Ianopol L; Galan L; Fleşeriu M; Onciu C; Bogos L; Lupovici R; Boghiţoiu G; Ohmt E; Popescu G; Mihailiuc I; Maftei S; Tapu T; Zebreniuc D
Arch Roum Pathol Exp Microbiol; 1973 Mar; 32(1):35-44. PubMed ID: 4585403
[No Abstract] [Full Text] [Related]
13. Construction of a stable and non-resistant bivalent vaccine candidate strain against Shigella flexneri 2a and Shigella sonnei.
Rui X; Xu Y; Wan H; Su G; Huang C
Chin J Biotechnol; 1996; 12(2):89-97. PubMed ID: 8988355
[TBL] [Abstract][Full Text] [Related]
14. [Live shigella flexneri 2a and shigella sonnei vaccines (author's transl)].
Belaia IuA; Gekker VD; Kuz'min SN; Sergeeva NS
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):63-9. PubMed ID: 4216253
[No Abstract] [Full Text] [Related]
15. Efficacy of a polyvalent protein-polysaccharide dysentery oral vaccine.
Zhang HM; Li YP; Song LH; Yu XL; Liu NH; Kong XE; Li L; Zhai YL
Chin Med J (Engl); 1987 May; 100(5):425-8. PubMed ID: 3115716
[No Abstract] [Full Text] [Related]
16. Immunogenic value of live, inactivated and cell-free dysentery vaccines.
Meitert T; Sulea IT; Gogulescu L; Baron E; Tempea C; Istrati G
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):103-7. PubMed ID: 4613127
[No Abstract] [Full Text] [Related]
17. Shigellosis: the current status of vaccine development.
Kweon MN
Curr Opin Infect Dis; 2008 Jun; 21(3):313-8. PubMed ID: 18448978
[TBL] [Abstract][Full Text] [Related]
18. Reduction of morbidity due to bacillary dysentery by live vaccine Vadizen (Sh. flexneri T32-Istrati) in children collectivities in BH County.
Pop C; Cernea L; Ciortea A; Ianossy L; Kallay T; Lugoş A; Meitert T; Ciudin L; Pencu E
Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):351-6. PubMed ID: 6400310
[No Abstract] [Full Text] [Related]
19. Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines.
Robin G; Keisari Y; Slepon R; Ashkenazi S; Cohen D
Vaccine; 1999 Aug; 17(23-24):3109-15. PubMed ID: 10462247
[TBL] [Abstract][Full Text] [Related]
20. [Oral vaccination using live, apathogenic nondependent Shigella organisms].
Meitert T; Istrati G; Ciufecu C; Sulea IT
Z Gesamte Hyg; 1972 Oct; 18(10):753-6. PubMed ID: 4581672
[No Abstract] [Full Text] [Related]
[Next] [New Search]
